Carbidopa-Levodopa 25mg-250mg CR

Carbidopa-Levodopa 25mg-250mg CR Tablets – Complete Product Description

Carbidopa-Levodopa 25mg-250mg CR (Controlled Release) is a prescription medication used in the treatment and long-term management of Parkinson’s disease and Parkinsonian syndromes. This controlled-release formulation combines 25mg of Carbidopa with 250mg of Levodopa to help replenish dopamine levels in the brain while providing extended symptom control throughout the day.

Parkinson’s disease is a progressive neurological disorder caused by the loss of dopamine-producing nerve cells. As dopamine levels decline, patients may experience symptoms such as tremors, muscle rigidity, slow movements, balance problems, and impaired coordination. Carbidopa-Levodopa 25mg-250mg CR helps improve motor function and daily activities by restoring dopamine activity in the central nervous system.

Uses of Carbidopa-Levodopa 25mg-250mg CR

Carbidopa-Levodopa 25mg-250mg CR is commonly prescribed for:

• Parkinson’s disease
• Parkinsonian syndromes
• Management of motor fluctuations
• Reduction of “wearing-off” symptoms between doses
• Treatment of tremors and muscle stiffness
• Improvement of mobility and movement control
• Long-term dopamine replacement therapy

How Carbidopa-Levodopa 25mg-250mg CR Works

Levodopa is converted into dopamine after entering the brain, helping replace the dopamine deficiency responsible for Parkinson’s disease symptoms. Increased dopamine levels improve communication between nerve cells involved in movement and coordination.

Carbidopa prevents Levodopa from being broken down before it reaches the brain, increasing the amount of active medication available for therapeutic benefit. The controlled-release formulation gradually releases the medication over time, helping provide sustained symptom relief and reducing fluctuations in motor performance.

Benefits of Carbidopa-Levodopa 25mg-250mg CR

• Provides extended symptom management
• Helps maintain more consistent dopamine levels
• May reduce “off” periods between doses
• Improves walking, balance, and coordination
• Supports smoother movement throughout the day
• Reduces muscle rigidity and stiffness
• Enhances quality of life for Parkinson’s patients

Dosage and Administration

Carbidopa-Levodopa 25mg-250mg CR should be used exactly as prescribed by a healthcare professional. Treatment plans are individualized based on disease severity, previous therapy, and patient response.

Controlled-release tablets should generally be swallowed whole with water. Crushing, chewing, or splitting the tablet may interfere with the controlled-release mechanism and affect treatment effectiveness.

Regular monitoring and follow-up visits are recommended to ensure optimal symptom control and dosage adjustments when necessary.

Possible Side Effects

Like all medications, Carbidopa-Levodopa 25mg-250mg CR may cause side effects, although not everyone experiences them.

• Nausea
• Dizziness
• Drowsiness
• Headache
• Dry mouth
• Constipation
• Sleep disturbances
• Low blood pressure upon standing
• Involuntary movements (dyskinesia)

Seek immediate medical attention if you experience severe allergic reactions, hallucinations, confusion, chest pain, significant behavioral changes, or worsening neurological symptoms.

Warnings and Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor about all prescription and non-prescription medications.
• Do not stop treatment suddenly without medical advice.
• Patients with glaucoma, heart disease, liver disease, or psychiatric conditions should use caution.
• Exercise caution when driving or operating machinery.
• Routine medical monitoring may be required during long-term therapy.

Storage Instructions

• Store below 25°C in a cool, dry place.
• Protect from moisture and direct sunlight.
• Keep tablets in their original packaging.
• Keep out of reach of children and pets.
• Do not use after the expiry date.

Related Healthcare Resources

Discover expert articles on Parkinson’s disease, neurological health, and medication management in our
Healthcare Blog.

Need assistance with prescriptions or product-related questions? Visit our
Contact Us Page.

For official prescribing information and patient education resources, visit

MedlinePlus – Carbidopa and Levodopa Drug Information
.

Frequently Asked Questions (FAQs)

1. What is Carbidopa-Levodopa 25mg-250mg CR used for?

Carbidopa-Levodopa 25mg-250mg CR is used to manage Parkinson’s disease and related movement disorders by helping restore dopamine levels in the brain.

2. What does the Controlled Release (CR) formulation do?

The CR formulation releases medication gradually over an extended period, helping maintain consistent symptom control and reducing fluctuations between doses.

3. Can I break or crush Carbidopa-Levodopa 25mg-250mg CR tablets?

No. Controlled-release tablets should typically be swallowed whole because altering the tablet may affect the medication’s extended-release properties.

4. How long does Carbidopa-Levodopa 25mg-250mg CR last?

The controlled-release formulation is designed to provide longer-lasting symptom relief compared to immediate-release versions, although duration varies among patients.

5. Can Carbidopa-Levodopa 25mg-250mg CR cure Parkinson’s disease?

No. While it does not cure Parkinson’s disease, it helps control symptoms, improve mobility, and support a better quality of life.

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Carbidopa-Levodopa 25mg-250mg CR should be used only under professional medical supervision.